___

• Kaynaklar 1.Güçer H, Renal Hücreli Karsinomlarda COX-2 Ekspresyonuve Mikrodamar Yoğunluğunun Klinikopatolojik Parametre-lerle Karşılaştırılması. Uzmanlık Tezi 2006 2.Yörükoğlu K, Böbrek Hücreli Kanserlerde Sınıflama, Sitoge-netik ve Patolojik Prognostik Faktörler. Dokuz Eylül Üniver-sitesi Tıp Fakültesi Patoloji Anabilim Dalı 3.Özen A, Dündar Kasapoğlu E, Açıkalın MF,Can C. BerrakHücreli Renal Hücreli Karsinomda Fuhrman Derecesinin Tek-rarlanabilirliğinin ve Prognostik Kullanımının Değerlendiril-mesi. Osmangazi Tıp Dergisi 36(3), 13-20. 4. Novick AC, Campbell SC. Renal Tumors. In: Walsh PC, Re-tik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology.Philadelphia: WB Saunders 2002; 2672-731. 5.Çelik O, Yüksel MB, İpekçi T, Aydoğdu Ö. Renal Hücreli Kan-serde Güncel Tanı ve Tedavi Yöntemleri. The Cystoscop on-line dergi e-ISSN:2148-1347, 166-177 6. Catalona C, Fraioli F, Laghi A. High resolution multidetec-tor CT in the preoperative evaluation of patientswith renal cellcarcinoma. Am J Roentgenol 2003; 180(5): 1271-7. 7. Sheth S, Scatarige JC, Horton KM, Fishman EK. Current con-cepts in the diagnosis and manegement ofrenal cell carcino-ma: role of multidetector CT and three-dimensional CT. Ra-diographics 2001; 21: 237-54. 8. Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T.Immunotherapy for advanced renal cellcancer. Cochrane Da-tabase Syst Rev 2005. 9.Eble JN, Sauter G, Epstein JI, Sesterhenn IA: World Health Organization Classification of Tumors. Pathology and Gene-tics of Tumors of the Urinary System and male Genital Or-gans. IARC Press: Lyon, 2004 10. Srigley JR, Hutter RV, Gelb AB, Henson DE, Kenney G, KingBF, Raziuddin S, Pisansky TM: Current prognostic factors--renal cell carcinoma: Workgroup No.4. Union Internationa-le Contre le Cancer (UICC) and the American Joint Commit-tee on Cancer (AJCC). Cancer, 80: 994-996, 1997 11. Kirkali Z, Lekili M: Renal cell carcinoma: New prognostic fac-tors? Curr Opin Urol, 13: 433-438, 2003. 12. Permpongkosol S, Lind RE, Solomon SB, Kavoussi LR. Re-sult of computerized tomography guidedpercutaneous abla-tion of renal masses with nondiagnostic pre-ablation patho-logical findings. J Urol 2006;176(2): 463-7; discussion 467 13. Hegarty N, Gill I, Kaouk JH, Spaliviero M, Desai M, NovickAC, Remer E. Renal cryoablation: 5-yearoutcomes. J Urol2006; 175; 351. 14. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Longterm follow-up of patients with renal cellcarcinoma treatedwith radiofrequency ablation with curative intent. J Urol 2005;174(1): 61-3 15. Varkarakis IM, Ellaf ME, Inaki T, Bhayani SB, Chan DY, SuLM, et al. Percutaneous radiofrequencyablation of renal mas-ses: Results at a 2 year mean follow-up. J Urol 2005;174(2): 456-60;discussion 460. 16.Ljungberg B, Landberg G, Alamdari FI. Factors of importan-ce for prediction of survival in patients withmetastatic renalcell carcinoma, treated with or without nephrectomy. ScandJ Urol Nephrol 2000; 34:246-51.